Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.
Immune-driven dry eye disease primarily affects women; the cause for this sex-specific prevalence is unknown. Polymorphonuclear neutrophils (PMN) have distinct phenotypes that drive inflammation but also regulate lymphocytes and are the rate-limiting cell for generating anti-inflammatory lipoxin A4 (LXA4). Estrogen regulates the LXA4 circuit to induce delayed female-specific wound healing in the cornea. However, the role of PMNs in dry eye disease remains unexplored. We discovered an LXA4-producing tissue PMN population in the corneal limbus, lacrimal glands, and cervical lymph nodes of healthy male and female mice. These tissue PMNs, unlike inflammatory PMNs, expressed a highly amplified LXA4 circuit and were sex-specifically regulated during immune-driven dry eye disease. Desiccating stress in females, unlike in males, triggered a remarkable decrease in lymph node PMN and LXA4 formation that remained depressed during dry eye disease. Depressed lymph node PMN and LXA4 in females correlated with an increase in effector T cells (Th1 and Th17), a decrease in regulatory T cells (Treg), and increased dry eye pathogenesis. Ab depletion of tissue PMN abrogated LXA4 formation in lymph nodes, as well as caused a marked increase in Th1 and Th17 cells and a decrease in Tregs. To establish an immune-regulatory role for PMN-derived LXA4 in dry eye, females were treated with LXA4. LXA4 treatment markedly inhibited Th1 and Th17 and amplified Treg in draining lymph nodes, while reducing dry eye pathogenesis. These results identify female-specific regulation of LXA4-producing tissue PMN as a potential key factor in aberrant effector T cell activation and initiation of immune-driven dry eye disease.
Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598.
Yuan
Y
Gao
Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598.
Kyungji
K
Min
Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598.
Yibing
Y
Zhang
Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598.
John
J
Su
Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598.
Matthew
M
Greenwood
Vision Science Program, School of Optometry, University of California Berkeley, Berkeley, CA 94598 kgronert@berkeley.edu.
Karsten
K
Gronert
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology*; D015536:Down-Regulation; D015352:Dry Eye Syndromes / Q000276:immunology*; D004967:Estrogens / Q000378:metabolism; D005260:Female; D007765:Lacrimal Apparatus / Q000378:metabolism; D016850:Limbus Corneae / Q000378:metabolism / Q000502:physiology; D044045:Lipoxins / Q000096:biosynthesis / Q000494:pharmacology*; D008198:Lymph Nodes / Q000378:metabolism; D008213:Lymphocyte Activation / Q000276:immunology; D018655:Lymphocyte Count; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009504:Neutrophils / Q000276:immunology; D012737:Sex Factors; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D058504:Th17 Cells / Q000276:immunology*; D014945:Wound Healing / Q000502:physiology
D004967:Estrogens; D044045:Lipoxins; C040527:lipoxin A4